,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,GO_Biological_Process_2018,metal ion homeostasis (GO:0055065),2/45,0.000740201623342803,0.0738314003456261,0,0,57.96220930232558,417.82568323656506,LETMD1;SLC12A9
24,GO_Biological_Process_2018,myoblast differentiation (GO:0045445),1/16,0.0143084109196949,0.0738314003456261,0,0,78.30196078431372,332.5412031884909,NRG1
23,GO_Biological_Process_2018,mRNA transcription from RNA polymerase II promoter (GO:0042789),1/16,0.0143084109196949,0.0738314003456261,0,0,78.30196078431372,332.5412031884909,TFCP2
22,GO_Biological_Process_2018,regulation of protein homodimerization activity (GO:0043496),1/16,0.0143084109196949,0.0738314003456261,0,0,78.30196078431372,332.5412031884909,NRG1
20,GO_Biological_Process_2018,mesenchymal cell development (GO:0014031),1/15,0.01341982690512,0.0738314003456261,0,0,83.89915966386555,361.6911269349327,NRG1
19,GO_Biological_Process_2018,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,0.01341982690512,0.0738314003456261,0,0,83.89915966386555,361.6911269349327,KCND3
18,GO_Biological_Process_2018,cardiac muscle cell differentiation (GO:0055007),1/15,0.01341982690512,0.0738314003456261,0,0,83.89915966386555,361.6911269349327,NRG1
17,GO_Biological_Process_2018,neural crest cell differentiation (GO:0014033),1/15,0.01341982690512,0.0738314003456261,0,0,83.89915966386555,361.6911269349327,NRG1
16,GO_Biological_Process_2018,negative regulation of secretion (GO:0051048),1/14,0.0125304865571366,0.0738314003456261,0,0,90.3574660633484,395.7287161899813,NRG1
15,GO_Biological_Process_2018,stem cell development (GO:0048864),1/14,0.0125304865571366,0.0738314003456261,0,0,90.3574660633484,395.7287161899813,NRG1
14,GO_Biological_Process_2018,regulation of secretion (GO:0051046),1/14,0.0125304865571366,0.0738314003456261,0,0,90.3574660633484,395.7287161899813,NRG1
13,GO_Biological_Process_2018,cardiocyte differentiation (GO:0035051),1/13,0.011640389286531,0.0738314003456261,0,0,97.8921568627451,435.94063546940737,NRG1
21,GO_Biological_Process_2018,monovalent inorganic anion homeostasis (GO:0055083),1/15,0.01341982690512,0.0738314003456261,0,0,83.89915966386555,361.6911269349327,SLC12A9
11,GO_Biological_Process_2018,viral RNA genome replication (GO:0039694),1/12,0.0107495345067081,0.0738314003456261,0,0,106.79679144385028,484.0984098875249,ATG16L1
10,GO_Biological_Process_2018,membrane repolarization during action potential (GO:0086011),1/11,0.0098579216348164,0.0738314003456261,0,0,117.48235294117649,542.7073703814344,KCND3
9,GO_Biological_Process_2018,cardiac muscle cell membrane repolarization (GO:0099622),1/11,0.0098579216348164,0.0738314003456261,0,0,117.48235294117649,542.7073703814344,KCND3
8,GO_Biological_Process_2018,chloride ion homeostasis (GO:0055064),1/10,0.0089655500933473,0.0738314003456261,0,0,130.54248366013073,615.425022203049,SLC12A9
7,GO_Biological_Process_2018,potassium ion export (GO:0071435),1/9,0.0080724193100501,0.0738314003456261,0,0,146.86764705882354,707.7995527019895,KCND3
6,GO_Biological_Process_2018,regulation of striated muscle cell differentiation (GO:0051153),1/8,0.0071785287204102,0.0738314003456261,0,0,167.85714285714286,828.6537822644398,NRG1
5,GO_Biological_Process_2018,cellular cation homeostasis (GO:0030003),1/8,0.0071785287204102,0.0738314003456261,0,0,167.85714285714286,828.6537822644398,LETMD1
4,GO_Biological_Process_2018,ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,0.0071785287204102,0.0738314003456261,0,0,167.85714285714286,828.6537822644398,NRG1
3,GO_Biological_Process_2018,ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/8,0.0071785287204102,0.0738314003456261,0,0,167.85714285714286,828.6537822644398,KCND3
2,GO_Biological_Process_2018,regulation of protein heterodimerization activity (GO:0043497),1/7,0.0062838777740325,0.0738314003456261,0,0,195.843137254902,992.8792720611536,NRG1
1,GO_Biological_Process_2018,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,0.0053884659389882,0.0738314003456261,0,0,235.0235294117647,1227.644124299904,NRG1
12,GO_Biological_Process_2018,membrane repolarization (GO:0086009),1/13,0.011640389286531,0.0738314003456261,0,0,97.8921568627451,435.94063546940737,KCND3
33,GO_Biological_Process_2018,positive regulation of erythrocyte differentiation (GO:0045648),1/22,0.0196240651712844,0.0744560119734026,0,0,55.91316526610644,219.7945772360195,FAM210B
32,GO_Biological_Process_2018,regulation of ERBB signaling pathway (GO:1901184),1/22,0.0196240651712844,0.0744560119734026,0,0,55.91316526610644,219.7945772360195,NRG1
31,GO_Biological_Process_2018,protein O-linked glycosylation via serine (GO:0018242),1/22,0.0196240651712844,0.0744560119734026,0,0,55.91316526610644,219.7945772360195,GALNTL6
30,GO_Biological_Process_2018,mRNA transcription (GO:0009299),1/21,0.0187400067082949,0.0744560119734026,0,0,58.71176470588235,233.50224496360525,TFCP2
28,GO_Biological_Process_2018,cellular response to estradiol stimulus (GO:0071392),1/20,0.0178551954764704,0.0744560119734026,0,0,61.80495356037152,248.79341471282052,FAM210B
27,GO_Biological_Process_2018,striated muscle cell differentiation (GO:0051146),1/19,0.01696963087688,0.0744560119734026,0,0,65.24183006535948,265.9472259849427,NRG1
26,GO_Biological_Process_2018,heart trabecula morphogenesis (GO:0061384),1/18,0.0160833123117468,0.0744560119734026,0,0,69.08304498269896,285.3111137768628,NRG1
25,GO_Biological_Process_2018,positive regulation of striated muscle cell differentiation (GO:0051155),1/17,0.0151962391911868,0.0744560119734026,0,0,73.40441176470588,307.3227868353231,NRG1
29,GO_Biological_Process_2018,protein O-linked glycosylation via threonine (GO:0018243),1/21,0.0187400067082949,0.0744560119734026,0,0,58.71176470588235,233.50224496360525,GALNTL6
34,GO_Biological_Process_2018,mammary gland development (GO:0030879),1/24,0.0213899261577365,0.0788371564099431,0,0,51.0460358056266,196.26359569838613,NRG1
35,GO_Biological_Process_2018,potassium ion homeostasis (GO:0055075),1/25,0.0222717298790694,0.0798070320666655,0,0,48.91666666666666,186.10038260880103,SLC12A9
36,GO_Biological_Process_2018,monovalent inorganic cation homeostasis (GO:0055067),1/26,0.0231527832149216,0.0807218658033755,0,0,46.95764705882353,176.82560723797164,SLC12A9
37,GO_Biological_Process_2018,positive regulation of myeloid cell differentiation (GO:0045639),1/29,0.02579144685281,0.0839113681336515,0,0,41.92016806722689,153.33191684558912,FAM210B
38,GO_Biological_Process_2018,cardiac muscle cell action potential (GO:0086001),1/29,0.02579144685281,0.0839113681336515,0,0,41.92016806722689,153.33191684558912,KCND3
39,GO_Biological_Process_2018,activation of protein kinase B activity (GO:0032148),1/30,0.0266695046006179,0.0839113681336515,0,0,40.47261663286004,146.68225415832842,NRG1
40,GO_Biological_Process_2018,response to estradiol (GO:0032355),1/30,0.0266695046006179,0.0839113681336515,0,0,40.47261663286004,146.68225415832842,FAM210B
47,GO_Biological_Process_2018,cardiac muscle tissue development (GO:0048738),1/36,0.0319221763964905,0.0840400154111689,0,0,33.52436974789916,115.4731604004656,NRG1
48,GO_Biological_Process_2018,carbohydrate biosynthetic process (GO:0016051),1/36,0.0319221763964905,0.0840400154111689,0,0,33.52436974789916,115.4731604004656,GALNTL6
46,GO_Biological_Process_2018,neural crest cell development (GO:0014032),1/35,0.0310485941558708,0.0840400154111689,0,0,34.5121107266436,119.83301120641356,NRG1
45,GO_Biological_Process_2018,regulation of heart rate by cardiac conduction (GO:0086091),1/35,0.0310485941558708,0.0840400154111689,0,0,34.5121107266436,119.83301120641356,KCND3
43,GO_Biological_Process_2018,positive regulation of muscle cell differentiation (GO:0051149),1/34,0.030174267482518,0.0840400154111689,0,0,35.559714795008915,124.48623298308226,NRG1
42,GO_Biological_Process_2018,oligosaccharide biosynthetic process (GO:0009312),1/33,0.0292991957903235,0.0840400154111689,0,0,36.67279411764706,129.4621221594897,GALNTL6
41,GO_Biological_Process_2018,regulation of erythrocyte differentiation (GO:0045646),1/32,0.0284233784701102,0.0840400154111689,0,0,37.85768500948767,134.79392621731594,FAM210B
44,GO_Biological_Process_2018,ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/34,0.030174267482518,0.0840400154111689,0,0,35.559714795008915,124.48623298308226,NRG1
49,GO_Biological_Process_2018,potassium ion import (GO:0010107),1/38,0.0336671099659209,0.086861143712076,0,0,31.70906200317965,107.5328454820737,SLC12A9
50,GO_Biological_Process_2018,ERBB2 signaling pathway (GO:0038128),1/39,0.0345384624837867,0.087361993341343,0,0,30.87306501547988,103.9089106040704,NRG1
51,GO_Biological_Process_2018,negative regulation of transport (GO:0051051),1/40,0.035409072945574,0.0878417386534434,0,0,30.07993966817496,100.49067723322013,NRG1
52,GO_Biological_Process_2018,negative regulation of ERBB signaling pathway (GO:1901185),1/43,0.0380164579400951,0.0925306240428732,0,0,27.92717086834734,91.3144790197023,NRG1
187,GO_Biological_Process_2017b,negative regulation of ERBB3 signaling pathway (GO:1905579),1/14,0.0125304865571366,0.0930194035339315,0,0,90.3574660633484,395.7287161899813,NRG1
172,GO_Biological_Process_2017b,cardiac pacemaker cell differentiation (GO:0060920),1/11,0.0098579216348164,0.0930194035339315,0,0,117.48235294117649,542.7073703814344,NRG1
173,GO_Biological_Process_2017b,atrial cardiac muscle cell differentiation (GO:0055011),1/11,0.0098579216348164,0.0930194035339315,0,0,117.48235294117649,542.7073703814344,NRG1
174,GO_Biological_Process_2017b,cardiac neural crest cell development involved in heart development (GO:0061308),1/11,0.0098579216348164,0.0930194035339315,0,0,117.48235294117649,542.7073703814344,NRG1
175,GO_Biological_Process_2017b,negative stranded viral RNA replication (GO:0039689),1/11,0.0098579216348164,0.0930194035339315,0,0,117.48235294117649,542.7073703814344,ATG16L1
176,GO_Biological_Process_2017b,His-Purkinje system cell differentiation (GO:0060932),1/11,0.0098579216348164,0.0930194035339315,0,0,117.48235294117649,542.7073703814344,NRG1
177,GO_Biological_Process_2017b,positive regulation of myotube differentiation (GO:0010831),1/11,0.0098579216348164,0.0930194035339315,0,0,117.48235294117649,542.7073703814344,NRG1
178,GO_Biological_Process_2017b,cellular magnesium ion homeostasis (GO:0010961),1/11,0.0098579216348164,0.0930194035339315,0,0,117.48235294117649,542.7073703814344,LETMD1
182,GO_Biological_Process_2017b,cardiac muscle cell myoblast differentiation (GO:0060379),1/12,0.0107495345067081,0.0930194035339315,0,0,106.79679144385028,484.0984098875249,NRG1
180,GO_Biological_Process_2017b,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/12,0.0107495345067081,0.0930194035339315,0,0,106.79679144385028,484.0984098875249,KCND3
181,GO_Biological_Process_2017b,ventricular cardiac muscle cell differentiation (GO:0055012),1/12,0.0107495345067081,0.0930194035339315,0,0,106.79679144385028,484.0984098875249,NRG1
171,GO_Biological_Process_2017b,thelarche (GO:0042695),1/10,0.0089655500933473,0.0930194035339315,0,0,130.54248366013073,615.425022203049,NRG1
183,GO_Biological_Process_2017b,mammary gland morphogenesis (GO:0060443),1/12,0.0107495345067081,0.0930194035339315,0,0,106.79679144385028,484.0984098875249,NRG1
184,GO_Biological_Process_2017b,cardiac muscle cell development (GO:0055013),1/13,0.011640389286531,0.0930194035339315,0,0,97.8921568627451,435.94063546940737,NRG1
185,GO_Biological_Process_2017b,membrane repolarization during AV node cell action potential (GO:0086049),1/13,0.011640389286531,0.0930194035339315,0,0,97.8921568627451,435.94063546940737,KCND3
186,GO_Biological_Process_2017b,positive regulation of sarcomere organization (GO:0060298),1/14,0.0125304865571366,0.0930194035339315,0,0,90.3574660633484,395.7287161899813,NRG1
179,GO_Biological_Process_2017b,membrane repolarization during bundle of His cell action potential (GO:0086050),1/12,0.0107495345067081,0.0930194035339315,0,0,106.79679144385028,484.0984098875249,KCND3
170,GO_Biological_Process_2017b,mammary gland development (GO:0030879),1/10,0.0089655500933473,0.0930194035339315,0,0,130.54248366013073,615.425022203049,NRG1
165,GO_Biological_Process_2017b,cardiac muscle cell membrane repolarization (GO:0099622),1/9,0.0080724193100501,0.0930194035339315,0,0,146.86764705882354,707.7995527019895,KCND3
168,GO_Biological_Process_2017b,right ventricular trabecular myocardium morphogenesis (GO:0003227),1/10,0.0089655500933473,0.0930194035339315,0,0,130.54248366013073,615.425022203049,NRG1
151,GO_Biological_Process_2017b,negative regulation of gastric acid secretion (GO:0060455),1/6,0.0053884659389882,0.0930194035339315,0,0,235.0235294117647,1227.644124299904,NRG1
152,GO_Biological_Process_2017b,cellular aluminum ion homeostasis (GO:0010217),1/6,0.0053884659389882,0.0930194035339315,0,0,235.0235294117647,1227.644124299904,LETMD1
153,GO_Biological_Process_2017b,cellular transition metal ion homeostasis (GO:0046916),1/6,0.0053884659389882,0.0930194035339315,0,0,235.0235294117647,1227.644124299904,LETMD1
154,GO_Biological_Process_2017b,negative regulation of dehydroepiandrosterone secretion (GO:2000841),1/7,0.0062838777740325,0.0930194035339315,0,0,195.843137254902,992.8792720611536,NRG1
155,GO_Biological_Process_2017b,negative regulation of androstenedione secretion (GO:2000838),1/7,0.0062838777740325,0.0930194035339315,0,0,195.843137254902,992.8792720611536,NRG1
156,GO_Biological_Process_2017b,negative regulation of estrone secretion (GO:2000868),1/7,0.0062838777740325,0.0930194035339315,0,0,195.843137254902,992.8792720611536,NRG1
157,GO_Biological_Process_2017b,negative regulation of estradiol secretion (GO:2000865),1/7,0.0062838777740325,0.0930194035339315,0,0,195.843137254902,992.8792720611536,NRG1
169,GO_Biological_Process_2017b,left ventricular trabecular myocardium morphogenesis (GO:0003225),1/10,0.0089655500933473,0.0930194035339315,0,0,130.54248366013073,615.425022203049,NRG1
158,GO_Biological_Process_2017b,negative regulation of testosterone secretion (GO:2000844),1/7,0.0062838777740325,0.0930194035339315,0,0,195.843137254902,992.8792720611536,NRG1
160,GO_Biological_Process_2017b,negative regulation of saliva secretion (GO:1905747),1/8,0.0071785287204102,0.0930194035339315,0,0,167.85714285714286,828.6537822644398,NRG1
161,GO_Biological_Process_2017b,positive regulation of cardiac muscle cell differentiation (GO:2000727),1/8,0.0071785287204102,0.0930194035339315,0,0,167.85714285714286,828.6537822644398,NRG1
162,GO_Biological_Process_2017b,negative regulation of secretion (GO:0051048),1/8,0.0071785287204102,0.0930194035339315,0,0,167.85714285714286,828.6537822644398,NRG1
163,GO_Biological_Process_2017b,potassium ion export (GO:0071435),1/9,0.0080724193100501,0.0930194035339315,0,0,146.86764705882354,707.7995527019895,KCND3
164,GO_Biological_Process_2017b,cellular metal ion homeostasis (GO:0006875),1/9,0.0080724193100501,0.0930194035339315,0,0,146.86764705882354,707.7995527019895,LETMD1
166,GO_Biological_Process_2017b,potassium ion export from cell (GO:0098668),1/9,0.0080724193100501,0.0930194035339315,0,0,146.86764705882354,707.7995527019895,KCND3
167,GO_Biological_Process_2017b,membrane repolarization during Purkinje myocyte action potential (GO:0086051),1/9,0.0080724193100501,0.0930194035339315,0,0,146.86764705882354,707.7995527019895,KCND3
159,GO_Biological_Process_2017b,negative regulation of renal sodium excretion (GO:0035814),1/7,0.0062838777740325,0.0930194035339315,0,0,195.843137254902,992.8792720611536,NRG1
188,GO_Biological_Process_2017b,membrane repolarization during SA node cell action potential (GO:0086052),1/15,0.01341982690512,0.0930194035339315,0,0,83.89915966386555,361.6911269349327,KCND3
211,GO_Biological_Process_2017b,L-methionine biosynthetic process from O-phospho-L-homoserine and cystathionine (GO:0019283),1/17,0.0151962391911868,0.0930194035339315,0,0,73.40441176470588,307.3227868353231,PTPRB
190,GO_Biological_Process_2017b,ribose phosphate metabolic process (GO:0019693),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
216,GO_Biological_Process_2017b,mammary gland fat development (GO:0060611),1/17,0.0151962391911868,0.0930194035339315,0,0,73.40441176470588,307.3227868353231,NRG1
215,GO_Biological_Process_2017b,regulation of protein heterodimerization activity (GO:0043497),1/17,0.0151962391911868,0.0930194035339315,0,0,73.40441176470588,307.3227868353231,NRG1
214,GO_Biological_Process_2017b,cellular potassium ion homeostasis (GO:0030007),1/17,0.0151962391911868,0.0930194035339315,0,0,73.40441176470588,307.3227868353231,LETMD1
213,GO_Biological_Process_2017b,lipid X metabolic process (GO:2001289),1/17,0.0151962391911868,0.0930194035339315,0,0,73.40441176470588,307.3227868353231,PTPRB
212,GO_Biological_Process_2017b,mammary gland epithelium development (GO:0061180),1/17,0.0151962391911868,0.0930194035339315,0,0,73.40441176470588,307.3227868353231,NRG1
189,GO_Biological_Process_2017b,mesenchymal cell differentiation involved in mammary gland development (GO:0060610),1/15,0.01341982690512,0.0930194035339315,0,0,83.89915966386555,361.6911269349327,NRG1
210,GO_Biological_Process_2017b,molybdopterin cofactor metabolic process (GO:0043545),1/17,0.0151962391911868,0.0930194035339315,0,0,73.40441176470588,307.3227868353231,PTPRB
209,GO_Biological_Process_2017b,thiamine diphosphate metabolic process (GO:0042357),1/17,0.0151962391911868,0.0930194035339315,0,0,73.40441176470588,307.3227868353231,PTPRB
207,GO_Biological_Process_2017b,alditol phosphate metabolic process (GO:0052646),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
206,GO_Biological_Process_2017b,carbamoyl phosphate metabolic process (GO:0070408),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
205,GO_Biological_Process_2017b,methanopterin-containing compound metabolic process (GO:2001115),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
204,GO_Biological_Process_2017b,regulation of protein homodimerization activity (GO:0043496),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,NRG1
208,GO_Biological_Process_2017b,phosphagen metabolic process (GO:0006599),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
202,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde (GO:0061720),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
191,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to 3-sulfopropanediol(1-) (GO:0061721),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
192,GO_Biological_Process_2017b,nucleoside phosphate metabolic process (GO:0006753),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
203,GO_Biological_Process_2017b,O3-(N-acetylglucosamine-1-phosphoryl)-L-serine biosynthetic process (GO:0018425),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
194,GO_Biological_Process_2017b,xylulose 5-phosphate metabolic process (GO:0051167),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
195,GO_Biological_Process_2017b,phosphate-containing compound metabolic process (GO:0006796),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
196,GO_Biological_Process_2017b,deoxyribose phosphate metabolic process (GO:0019692),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
193,GO_Biological_Process_2017b,D-tagatose 6-phosphate metabolic process (GO:2001058),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
197,GO_Biological_Process_2017b,D-glycero-D-manno-heptose 7-phosphate metabolic process (GO:2001060),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
198,GO_Biological_Process_2017b,"cyclic 2,3-bisphospho-D-glycerate biosynthetic process (GO:1901369)",1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
199,GO_Biological_Process_2017b,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
200,GO_Biological_Process_2017b,glucose 1-phosphate metabolic process (GO:0019255),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
201,GO_Biological_Process_2017b,1-deoxy-D-xylulose 5-phosphate metabolic process (GO:0052863),1/16,0.0143084109196949,0.0930194035339315,0,0,78.30196078431372,332.5412031884909,PTPRB
217,GO_Biological_Process_2017b,"7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)",1/18,0.0160833123117468,0.0941689590426914,0,0,69.08304498269896,285.3111137768628,PTPRB
218,GO_Biological_Process_2017b,"fructose 2,6-bisphosphate metabolic process (GO:0006003)",1/18,0.0160833123117468,0.0941689590426914,0,0,69.08304498269896,285.3111137768628,PTPRB
219,GO_Biological_Process_2017b,cardiac muscle cell fate commitment (GO:0060923),1/18,0.0160833123117468,0.0941689590426914,0,0,69.08304498269896,285.3111137768628,NRG1
220,GO_Biological_Process_2017b,membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),1/19,0.01696963087688,0.0952184843647156,0,0,65.24183006535948,265.9472259849427,KCND3
221,GO_Biological_Process_2017b,pyridoxal phosphate metabolic process (GO:0042822),1/19,0.01696963087688,0.0952184843647156,0,0,65.24183006535948,265.9472259849427,PTPRB
222,GO_Biological_Process_2017b,GDP-mannose biosynthetic process from fructose-6-phosphate (GO:0061729),1/19,0.01696963087688,0.0952184843647156,0,0,65.24183006535948,265.9472259849427,PTPRB
143,WikiPathways_2019_Human,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,1/53,0.0466597514614696,0.0967591718194837,0,0,22.54524886877828,69.09833217880467,NRG1
141,WikiPathways_2019_Human,Exercise-induced Circadian Regulation WP410,1/48,0.0423473138141528,0.0967591718194837,0,0,24.94993742177722,78.88796682594588,ETV6
142,WikiPathways_2019_Human,Cardiac Progenitor Differentiation WP2406,1/53,0.0466597514614696,0.0967591718194837,0,0,22.54524886877828,69.09833217880467,NRG1
140,WikiPathways_2019_Human,Nanoparticle triggered autophagic cell death WP2509,1/23,0.0205073714570783,0.0967591718194837,0,0,53.36898395721925,207.44368622737056,ATG16L1
144,WikiPathways_2019_Human,Cardiac Hypertrophic Response WP2795,1/55,0.0483795859097418,0.0967591718194837,0,0,21.70806100217865,65.7467122997584,NRG1
139,WikiPathways_2019_Human,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,1/20,0.0178551954764704,0.0967591718194837,0,0,61.80495356037152,248.79341471282052,ETV6
53,GO_Biological_Process_2018,regulation of cellular component movement (GO:0051270),1/46,0.0406171857845244,0.0970299438185862,0,0,26.06143790849673,83.48948444789488,NRG1
223,GO_Biological_Process_2017b,glucose 6-phosphate metabolic process (GO:0051156),1/20,0.0178551954764704,0.0988150544177267,0,0,61.80495356037152,248.79341471282052,PTPRB
225,GO_Biological_Process_2017b,cardiac muscle cell differentiation (GO:0055007),1/21,0.0187400067082949,0.0996179303967257,0,0,58.71176470588235,233.50224496360525,NRG1
224,GO_Biological_Process_2017b,neural crest cell development (GO:0014032),1/21,0.0187400067082949,0.0996179303967257,0,0,58.71176470588235,233.50224496360525,NRG1
226,GO_Biological_Process_2017b,tyrosine catabolic process to phosphoenolpyruvate (GO:0019446),1/21,0.0187400067082949,0.0996179303967257,0,0,58.71176470588235,233.50224496360525,PTPRB
228,GO_Biological_Process_2017b,fructose 6-phosphate metabolic process (GO:0006002),1/22,0.0196240651712844,0.1010363179104836,0,0,55.91316526610644,219.7945772360195,PTPRB
229,GO_Biological_Process_2017b,membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),1/23,0.0205073714570783,0.1010363179104836,0,0,53.36898395721925,207.44368622737056,KCND3
227,GO_Biological_Process_2017b,neural crest cell migration (GO:0001755),1/22,0.0196240651712844,0.1010363179104836,0,0,55.91316526610644,219.7945772360195,NRG1
231,GO_Biological_Process_2017b,glycerol to glycerone phosphate metabolic process (GO:0061610),1/23,0.0205073714570783,0.1010363179104836,0,0,53.36898395721925,207.44368622737056,PTPRB
230,GO_Biological_Process_2017b,membrane repolarization during action potential (GO:0086011),1/23,0.0205073714570783,0.1010363179104836,0,0,53.36898395721925,207.44368622737056,KCND3
232,GO_Biological_Process_2017b,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",1/23,0.0205073714570783,0.1010363179104836,0,0,53.36898395721925,207.44368622737056,PTPRB
233,GO_Biological_Process_2017b,lactation (GO:0007595),1/24,0.0213899261577365,0.1028753591395899,0,0,51.0460358056266,196.26359569838613,NRG1
234,GO_Biological_Process_2017b,cellular sodium ion homeostasis (GO:0006883),1/24,0.0213899261577365,0.1028753591395899,0,0,51.0460358056266,196.26359569838613,LETMD1
54,GO_Biological_Process_2018,wound healing (GO:0042060),1/50,0.0440744949316926,0.1033747244761519,0,0,23.92917166866747,74.70385911458476,NRG1
235,GO_Biological_Process_2017b,regulation of amoeboid sperm motility (GO:1905416),1/26,0.0231527832149216,0.1039302713203149,0,0,46.95764705882353,176.82560723797164,NRG1
236,GO_Biological_Process_2017b,regulation of cilium-dependent cell motility (GO:1902019),1/26,0.0231527832149216,0.1039302713203149,0,0,46.95764705882353,176.82560723797164,NRG1
237,GO_Biological_Process_2017b,regulation of bacterial-type flagellum-dependent cell motility (GO:1902021),1/26,0.0231527832149216,0.1039302713203149,0,0,46.95764705882353,176.82560723797164,NRG1
238,GO_Biological_Process_2017b,modulation by symbiont of host cell motility (GO:1903653),1/26,0.0231527832149216,0.1039302713203149,0,0,46.95764705882353,176.82560723797164,NRG1
239,GO_Biological_Process_2017b,positive regulation of striated muscle cell differentiation (GO:0051155),1/26,0.0231527832149216,0.1039302713203149,0,0,46.95764705882353,176.82560723797164,NRG1
240,GO_Biological_Process_2017b,regulation of flagellated sperm motility (GO:1901317),1/26,0.0231527832149216,0.1039302713203149,0,0,46.95764705882353,176.82560723797164,NRG1
241,GO_Biological_Process_2017b,regulation of cell motility (GO:2000145),1/27,0.0240330867565966,0.1055365983659242,0,0,45.14932126696833,168.33128827465845,NRG1
242,GO_Biological_Process_2017b,negative regulation of ERBB signaling pathway (GO:1901185),1/27,0.0240330867565966,0.1055365983659242,0,0,45.14932126696833,168.33128827465845,NRG1
57,GO_Biological_Process_2018,autophagosome assembly (GO:0000045),1/58,0.0509538444953197,0.1133283782740731,0,0,20.562435500516,61.21097903869968,ATG16L1
56,GO_Biological_Process_2018,chloride transmembrane transport (GO:1902476),1/57,0.0500964899328297,0.1133283782740731,0,0,20.930672268907564,62.66233736405012,SLC12A9
55,GO_Biological_Process_2018,autophagosome organization (GO:1905037),1/56,0.0492384039303871,0.1133283782740731,0,0,21.31229946524064,64.173068346434,ATG16L1
244,GO_Biological_Process_2017b,phosphorylated carbohydrate dephosphorylation (GO:0046838),1/30,0.0266695046006179,0.1134155774594699,0,0,40.47261663286004,146.68225415832842,PTPRB
245,GO_Biological_Process_2017b,phenylalanine catabolic process to phosphoenolpyruvate (GO:0019562),1/30,0.0266695046006179,0.1134155774594699,0,0,40.47261663286004,146.68225415832842,PTPRB
243,GO_Biological_Process_2017b,polynucleotide dephosphorylation (GO:0098501),1/30,0.0266695046006179,0.1134155774594699,0,0,40.47261663286004,146.68225415832842,PTPRB
246,GO_Biological_Process_2017b,phosphoanandamide dephosphorylation (GO:0035644),1/31,0.0275468149406694,0.1147310642889739,0,0,39.12156862745098,140.51952455455398,PTPRB
247,GO_Biological_Process_2017b,ventricular trabecula myocardium morphogenesis (GO:0003222),1/31,0.0275468149406694,0.1147310642889739,0,0,39.12156862745098,140.51952455455398,NRG1
62,GO_Biological_Process_2018,O-glycan processing (GO:0016266),1/65,0.0569348954637786,0.1165809764258323,0,0,18.30698529411765,52.46501611587855,GALNTL6
61,GO_Biological_Process_2018,inorganic anion transmembrane transport (GO:0098661),1/64,0.0560826445470321,0.1165809764258323,0,0,18.598506069094302,53.58097327195968,SLC12A9
60,GO_Biological_Process_2018,negative regulation of dephosphorylation (GO:0035305),1/63,0.0552296663042342,0.1165809764258323,0,0,18.89943074003795,54.73757147758474,CSRNP2
59,GO_Biological_Process_2018,oligosaccharide metabolic process (GO:0009311),1/63,0.0552296663042342,0.1165809764258323,0,0,18.89943074003795,54.73757147758474,GALNTL6
58,GO_Biological_Process_2018,potassium ion transport (GO:0006813),1/61,0.0535215254426699,0.1165809764258323,0,0,19.531372549019608,57.18144005818292,KCND3
248,GO_Biological_Process_2017b,regulation of cell motility involved in somitogenic axis elongation (GO:0090249),1/32,0.0284233784701102,0.1171739275706586,0,0,37.85768500948767,134.79392621731594,NRG1
145,WikiPathways_2019_Human,MicroRNAs in cardiomyocyte hypertrophy WP1544,1/84,0.0729902413804037,0.1182600373680141,0,0,14.10276399716513,36.91299089130259,NRG1
146,WikiPathways_2019_Human,ErbB Signaling Pathway WP673,1/91,0.0788400249120094,0.1182600373680141,0,0,13.001307189542484,33.02766894797317,NRG1
63,GO_Biological_Process_2018,negative regulation of phosphatase activity (GO:0010923),1/68,0.0594872899827324,0.1199040688714451,0,0,17.484635645302898,49.34151245692923,CSRNP2
147,WikiPathways_2019_Human,Senescence and Autophagy in Cancer WP615,1/105,0.0904351615790965,0.1205802154387954,0,0,11.243212669683258,27.0188131977752,ATG16L1
250,GO_Biological_Process_2017b,substrate localization to autophagosome (GO:0061753),1/34,0.030174267482518,0.1219040406293727,0,0,35.559714795008915,124.48623298308226,ATG16L1
249,GO_Biological_Process_2017b,regulation of heart rate by cardiac conduction (GO:0086091),1/34,0.030174267482518,0.1219040406293727,0,0,35.559714795008915,124.48623298308226,KCND3
251,GO_Biological_Process_2017b,autophagosome assembly (GO:0000045),1/35,0.0310485941558708,0.1241943766234833,0,0,34.5121107266436,119.83301120641356,ATG16L1
64,GO_Biological_Process_2018,regulation of phosphatase activity (GO:0010921),1/72,0.0628803352568931,0.1245569046178939,0,0,16.496271748135875,45.63729539644487,CSRNP2
65,GO_Biological_Process_2018,chloride transport (GO:0006821),1/73,0.063726788409155,0.1245569046178939,0,0,16.266339869281047,44.783677915691136,SLC12A9
253,GO_Biological_Process_2017b,wound healing (GO:0042060),1/36,0.0319221763964905,0.125209313244487,0,0,33.52436974789916,115.4731604004656,NRG1
252,GO_Biological_Process_2017b,epiboly involved in wound healing (GO:0090505),1/36,0.0319221763964905,0.125209313244487,0,0,33.52436974789916,115.4731604004656,NRG1
66,GO_Biological_Process_2018,gland development (GO:0048732),1/75,0.0654175289767128,0.1259531528059098,0,0,15.825119236883944,43.154546742931096,NRG1
254,GO_Biological_Process_2017b,wound healing involved in inflammatory response (GO:0002246),1/37,0.0327950148043916,0.1273960190478289,0,0,32.591503267973856,111.38077026649428,NRG1
255,GO_Biological_Process_2017b,angiogenesis involved in wound healing (GO:0060055),1/38,0.0336671099659209,0.1283161549644533,0,0,31.70906200317965,107.5328454820737,NRG1
256,GO_Biological_Process_2017b,ERBB2-ERBB4 signaling pathway (GO:0038135),1/38,0.0336671099659209,0.1283161549644533,0,0,31.70906200317965,107.5328454820737,NRG1
257,GO_Biological_Process_2017b,negative regulation of cell motility (GO:2000146),1/39,0.0345384624837867,0.1291994337356468,0,0,30.87306501547988,103.9089106040704,NRG1
258,GO_Biological_Process_2017b,ERBB2-ERBB3 signaling pathway (GO:0038133),1/39,0.0345384624837867,0.1291994337356468,0,0,30.87306501547988,103.9089106040704,NRG1
259,GO_Biological_Process_2017b,phospholipid dephosphorylation (GO:0046839),1/40,0.035409072945574,0.1300478679091994,0,0,30.07993966817496,100.49067723322013,PTPRB
260,GO_Biological_Process_2017b,engulfment of target by autophagosome (GO:0061736),1/40,0.035409072945574,0.1300478679091994,0,0,30.07993966817496,100.49067723322013,ATG16L1
68,GO_Biological_Process_2018,positive regulation of protein targeting to mitochondrion (GO:1903955),1/81,0.070472466450265,0.1317528720591911,0,0,14.633823529411766,38.81670264132201,NRG1
67,GO_Biological_Process_2018,ERBB signaling pathway (GO:0038127),1/80,0.0696317739420862,0.1317528720591911,0,0,14.819806403574088,39.48788238772356,NRG1
261,GO_Biological_Process_2017b,ERBB2 signaling pathway (GO:0038128),1/41,0.0362789419461595,0.1320422751914275,0,0,29.326470588235296,97.26176223664352,NRG1
69,GO_Biological_Process_2018,positive regulation of homeostatic process (GO:0032846),1/83,0.0721516995917754,0.1329652749619862,0,0,14.275466284074604,37.52997870137401,FAM210B
148,WikiPathways_2019_Human,Ectoderm Differentiation WP2858,1/138,0.1172235366155797,0.1348413114942376,0,0,8.520824388149421,18.26585775015061,PTPRB
149,WikiPathways_2019_Human,NRF2 pathway WP2884,1/146,0.1236045355363844,0.1348413114942376,0,0,8.047464503042596,16.82457683434384,NRG1
262,GO_Biological_Process_2017b,sucrose catabolic process via 3'-ketosucrose (GO:0019574),1/43,0.0380164579400951,0.1371307947124862,0,0,27.92717086834734,91.3144790197023,PTPRB
263,GO_Biological_Process_2017b,activation of protein kinase B activity (GO:0032148),1/44,0.0388841061194349,0.1377998146688746,0,0,27.276333789329687,88.57088446864675,NRG1
264,GO_Biological_Process_2017b,dephosphorylation (GO:0016311),1/44,0.0388841061194349,0.1377998146688746,0,0,27.276333789329687,88.57088446864675,PTPRB
70,GO_Biological_Process_2018,regulation of protein targeting to mitochondrion (GO:1903214),1/88,0.0763372567298681,0.1382669039977548,0,0,13.451656524678835,34.60565311468726,NRG1
71,GO_Biological_Process_2018,peptidyl-threonine modification (GO:0018210),1/89,0.0771722254871189,0.1382669039977548,0,0,13.29812834224599,34.06602362525984,GALNTL6
265,GO_Biological_Process_2017b,plasma membrane repair (GO:0001778),1/45,0.0397510152021215,0.1396470447100617,0,0,26.655080213903744,85.9658295948253,NRG1
266,GO_Biological_Process_2017b,phosphorylation (GO:0016310),1/46,0.0406171857845244,0.1414598539392058,0,0,26.06143790849673,83.48948444789488,PTPRB
267,GO_Biological_Process_2017b,positive regulation of cell motility (GO:2000147),1/47,0.0414826184608072,0.1432391269928727,0,0,25.493606138107417,81.1329113370927,NRG1
72,GO_Biological_Process_2018,cellular metal ion homeostasis (GO:0006875),1/96,0.0829970780395136,0.1466660694122913,0,0,12.313931888544891,30.64875924889407,LETMD1
73,GO_Biological_Process_2018,phosphatidylinositol biosynthetic process (GO:0006661),1/98,0.0846549330937291,0.1475741401228521,0,0,12.058823529411764,29.775308154544383,VAC14
75,GO_Biological_Process_2018,regulation of kinase activity (GO:0043549),1/101,0.0871364089944587,0.1479025889511206,0,0,11.69529411764706,28.539797811620943,VAC14
74,GO_Biological_Process_2018,metal ion transport (GO:0030001),1/101,0.0871364089944587,0.1479025889511206,0,0,11.69529411764706,28.539797811620943,KCND3
268,GO_Biological_Process_2017b,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/49,0.0432112724444188,0.1479436785385189,0,0,24.42892156862745,76.74721626832032,NRG1
76,GO_Biological_Process_2018,monovalent inorganic cation transport (GO:0015672),1/104,0.0896115305088417,0.1489626299075133,0,0,11.352941176470589,27.38637392725137,KCND3
78,GO_Biological_Process_2018,regulation of cell motility (GO:2000145),1/109,0.0937226537969026,0.1489626299075133,0,0,10.824618736383442,25.6263685491649,NRG1
79,GO_Biological_Process_2018,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/110,0.0945427716606664,0.1489626299075133,0,0,10.724770642201834,25.296548009342803,NRG1
80,GO_Biological_Process_2018,macroautophagy (GO:0016236),1/110,0.0945427716606664,0.1489626299075133,0,0,10.724770642201834,25.296548009342803,ATG16L1
81,GO_Biological_Process_2018,regulation of protein binding (GO:0043393),1/111,0.0953621885731626,0.1489626299075133,0,0,10.62673796791444,24.97361130786349,NRG1
82,GO_Biological_Process_2018,phosphatidylinositol metabolic process (GO:0046488),1/112,0.0961809050976451,0.1489626299075133,0,0,10.530471648118708,24.657356652146078,VAC14
83,GO_Biological_Process_2018,positive regulation of kinase activity (GO:0033674),1/113,0.0969989218002412,0.1489626299075133,0,0,10.4359243697479,24.3475898718272,VAC14
77,GO_Biological_Process_2018,negative regulation of hydrolase activity (GO:0051346),1/108,0.0929018344244166,0.1489626299075133,0,0,10.926333150082463,25.96328271398022,CSRNP2
269,GO_Biological_Process_2017b,negative regulation of protein homodimerization activity (GO:0090074),1/50,0.0440744949316926,0.1496310584235616,0,0,23.92917166866747,74.70385911458476,NRG1
84,GO_Biological_Process_2018,protein O-linked glycosylation (GO:0006493),1/115,0.0986328580009636,0.1496898668485212,0,0,10.251805985552116,23.74677927740439,GALNTL6
270,GO_Biological_Process_2017b,"negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001145)",1/51,0.0449369818711912,0.1500375262476138,0,0,23.44941176470588,72.75166337328601,CSRNP2
271,GO_Biological_Process_2017b,positive regulation of protein homodimerization activity (GO:0090073),1/51,0.0449369818711912,0.1500375262476138,0,0,23.44941176470588,72.75166337328601,NRG1
85,GO_Biological_Process_2018,activation of MAPK activity (GO:0000187),1/117,0.1002640016593071,0.1503960024889607,0,0,10.074036511156187,23.16976571809541,NRG1
273,GO_Biological_Process_2017b,negative regulation of alkaline phosphatase activity (GO:0010693),1/53,0.0466597514614696,0.1532564194344207,0,0,22.54524886877828,69.09833217880467,CSRNP2
272,GO_Biological_Process_2017b,dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),2/387,0.0465883385179153,0.1532564194344207,0,0,6.3626623376623375,19.51049970454832,PTPRB;TFCP2
274,GO_Biological_Process_2017b,negative regulation of phosphatidate phosphatase activity (GO:1903741),1/54,0.0475200352874264,0.1548233407751636,0,0,22.11875693673696,67.38709029166962,CSRNP2
275,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway (GO:0007173),1/55,0.0483795859097418,0.1563628216602857,0,0,21.70806100217865,65.7467122997584,NRG1
89,GO_Biological_Process_2018,positive regulation of mitochondrion organization (GO:0010822),1/128,0.1091855755847519,0.1564993250048111,0,0,9.196387216303844,20.36729685335,NRG1
86,GO_Biological_Process_2018,dephosphorylation (GO:0016311),1/124,0.1059510780315295,0.1564993250048111,0,0,9.49736967957915,21.31948479946905,PTPRB
87,GO_Biological_Process_2018,protein dephosphorylation (GO:0006470),1/125,0.1067607406651116,0.1564993250048111,0,0,9.420303605313093,21.074773673487663,PTPRB
88,GO_Biological_Process_2018,positive regulation of protein kinase B signaling (GO:0051897),1/127,0.1083779888894848,0.1564993250048111,0,0,9.26984126984127,20.598794838572697,NRG1
276,GO_Biological_Process_2017b,inositol phosphate metabolic process (GO:0043647),1/57,0.0500964899328297,0.1606268407370098,0,0,20.930672268907564,62.66233736405012,PTPRB
278,GO_Biological_Process_2017b,negative regulation of phosphatase activity (GO:0010923),1/58,0.0509538444953197,0.1608230716883528,0,0,20.562435500516,61.21097903869968,CSRNP2
277,GO_Biological_Process_2017b,protein localization to pre-autophagosomal structure (GO:0034497),1/58,0.0509538444953197,0.1608230716883528,0,0,20.562435500516,61.21097903869968,ATG16L1
279,GO_Biological_Process_2017b,phospholipid metabolic process (GO:0006644),1/59,0.051810468206973,0.1622591407412179,0,0,20.20689655172414,59.81570875382696,PTPRB
90,GO_Biological_Process_2018,cellular response to organic cyclic compound (GO:0071407),1/135,0.1148193693672815,0.1627659192129595,0,0,8.712906057945567,18.858171061974925,FAM210B
91,GO_Biological_Process_2018,positive regulation of transferase activity (GO:0051347),1/137,0.1164228335754234,0.1632450601220611,0,0,8.583910034602075,18.459926845841217,VAC14
92,GO_Biological_Process_2018,cellular protein complex assembly (GO:0043623),1/144,0.1220133823045622,0.1692443690031024,0,0,8.160839160839162,17.167341601168975,NRG1
280,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),3/991,0.0567784320313914,0.1755854791402027,0,0,3.8449392712550607,11.029587960907556,TFCP2;NRG1;ETV6
281,GO_Biological_Process_2017b,potassium ion transport (GO:0006813),1/65,0.0569348954637786,0.1755854791402027,0,0,18.30698529411765,52.46501611587855,KCND3
93,GO_Biological_Process_2018,positive regulation of intracellular protein transport (GO:0090316),1/152,0.1283616707475379,0.1761559098556637,0,0,7.725360342812622,15.859418874897433,NRG1
282,GO_Biological_Process_2017b,regulation of cell migration (GO:0030334),1/66,0.0577864196143044,0.1768614660922652,0,0,18.02443438914027,51.38768922197736,NRG1
129,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0275468149406694,0.1798526949909336,0,0,39.12156862745098,140.51952455455398,GALNTL6
138,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.1798526949909336,0.1798526949909336,0,0,5.332973556395035,9.149340756756814,VAC14
137,KEGG_2019_Human,Viral carcinogenesis,1/201,0.1663089555580513,0.1798526949909336,0,0,5.818235294117647,10.437379086756568,VAC14
136,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.1548614260771356,0.1798526949909336,0,0,6.294753577106518,11.741129142703194,ETV6
135,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.1486955362376284,0.1798526949909336,0,0,6.581920903954802,12.544183208435394,ATG16L1
132,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0780064813617029,0.1798526949909336,0,0,13.148050231328488,33.54019441349092,COL24A1
131,KEGG_2019_Human,ErbB signaling pathway,1/85,0.0738280674139551,0.1798526949909336,0,0,13.934173669467787,36.31268374332498,NRG1
130,KEGG_2019_Human,Adherens junction,1/72,0.0628803352568931,0.1798526949909336,0,0,16.496271748135875,45.63729539644487,PTPRB
133,KEGG_2019_Human,Autophagy,1/128,0.1091855755847519,0.1798526949909336,0,0,9.196387216303844,20.36729685335,ATG16L1
134,KEGG_2019_Human,Tight junction,1/170,0.1424871782645395,0.1798526949909336,0,0,6.896275670031327,13.43741562775988,ACTR3B
94,GO_Biological_Process_2018,regulation of protein kinase B signaling (GO:0051896),1/163,0.1370198116411668,0.1851726127636194,0,0,7.19680464778504,14.304583045111348,NRG1
95,GO_Biological_Process_2018,glycerophospholipid biosynthetic process (GO:0046474),1/164,0.1378028746147865,0.1851726127636194,0,0,7.152291591483219,14.175348854230412,VAC14
96,GO_Biological_Process_2018,peptidyl-serine modification (GO:0018209),1/170,0.1424871782645395,0.1889362016135135,0,0,6.896275670031327,13.43741562775988,GALNTL6
97,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter (GO:0006357),3/1478,0.1435329283575528,0.1889362016135135,0,0,2.5094237288135592,4.871270266212759,CSRNP2;TFCP2;ETV6
287,GO_Biological_Process_2017b,"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process (GO:1902635)",1/75,0.0654175289767128,0.1901344007668489,0,0,15.825119236883944,43.154546742931096,VAC14
285,GO_Biological_Process_2017b,phosphatidylinositol 5-phosphate biosynthetic process (GO:1904563),1/75,0.0654175289767128,0.1901344007668489,0,0,15.825119236883944,43.154546742931096,VAC14
286,GO_Biological_Process_2017b,negative regulation of phosphoprotein phosphatase activity (GO:0032515),1/75,0.0654175289767128,0.1901344007668489,0,0,15.825119236883944,43.154546742931096,CSRNP2
288,GO_Biological_Process_2017b,phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),1/75,0.0654175289767128,0.1901344007668489,0,0,15.825119236883944,43.154546742931096,VAC14
289,GO_Biological_Process_2017b,"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate biosynthetic process (GO:1903102)",1/75,0.0654175289767128,0.1901344007668489,0,0,15.825119236883944,43.154546742931096,VAC14
283,GO_Biological_Process_2017b,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),1/72,0.0628803352568931,0.1901344007668489,0,0,16.496271748135875,45.63729539644487,NRG1
284,GO_Biological_Process_2017b,ERBB2-EGFR signaling pathway (GO:0038134),1/73,0.063726788409155,0.1901344007668489,0,0,16.266339869281047,44.783677915691136,NRG1
290,GO_Biological_Process_2017b,ERBB signaling pathway (GO:0038127),1/76,0.0662618175517913,0.1912126735065979,0,0,15.613333333333332,42.376795202067306,NRG1
99,GO_Biological_Process_2018,cellular response to lipid (GO:0071396),1/178,0.1486955362376284,0.1918172417465407,0,0,6.581920903954802,12.544183208435394,FAM210B
98,GO_Biological_Process_2018,positive regulation of MAP kinase activity (GO:0043406),1/177,0.1479218196071764,0.1918172417465407,0,0,6.619652406417113,12.650628330192763,NRG1
100,GO_Biological_Process_2018,phosphate-containing compound metabolic process (GO:0006796),1/183,0.1525541767130676,0.1948464237226309,0,0,6.399482870071106,12.03253480284285,PTPRB
101,GO_Biological_Process_2018,protein homooligomerization (GO:0051260),1/190,0.1579285309548332,0.1997331420899361,0,0,6.160286336756925,11.369502600305925,ATG16L1
292,GO_Biological_Process_2017b,peptidyl-N-phospho-arginine dephosphorylation (GO:0098628),1/83,0.0721516995917754,0.200599030732538,0,0,14.275466284074604,37.52997870137401,PTPRB
293,GO_Biological_Process_2017b,peptidyl-histidine dephosphorylation (GO:0035971),1/83,0.0721516995917754,0.200599030732538,0,0,14.275466284074604,37.52997870137401,PTPRB
294,GO_Biological_Process_2017b,regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496),1/84,0.0729902413804037,0.200599030732538,0,0,14.10276399716513,36.91299089130259,PTPRB
295,GO_Biological_Process_2017b,activation of MAPK activity involved in osmosensory signaling pathway (GO:0000169),1/84,0.0729902413804037,0.200599030732538,0,0,14.10276399716513,36.91299089130259,NRG1
296,GO_Biological_Process_2017b,activation of MAPK activity involved in cell wall organization or biogenesis (GO:0000199),1/84,0.0729902413804037,0.200599030732538,0,0,14.10276399716513,36.91299089130259,NRG1
297,GO_Biological_Process_2017b,activation of MAPK activity involved in conjugation with cellular fusion (GO:0071508),1/84,0.0729902413804037,0.200599030732538,0,0,14.10276399716513,36.91299089130259,NRG1
291,GO_Biological_Process_2017b,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/82,0.0713124414727928,0.200599030732538,0,0,14.452432824981845,38.16431494463284,NRG1
298,GO_Biological_Process_2017b,activation of MAPK activity involved in innate immune response (GO:0035419),1/86,0.0746651782709374,0.2028749685633873,0,0,13.76955017301038,35.728422579909434,NRG1
300,GO_Biological_Process_2017b,peptidyl-serine dephosphorylation (GO:0070262),1/88,0.0763372567298681,0.2028749685633873,0,0,13.451656524678835,34.60565311468726,PTPRB
301,GO_Biological_Process_2017b,phosphatidylinositol biosynthetic process (GO:0006661),1/88,0.0763372567298681,0.2028749685633873,0,0,13.451656524678835,34.60565311468726,VAC14
302,GO_Biological_Process_2017b,positive regulation of protein import into mitochondrial outer membrane (GO:1903638),1/89,0.0771722254871189,0.2028749685633873,0,0,13.29812834224599,34.06602362525984,NRG1
303,GO_Biological_Process_2017b,peptidyl-threonine dephosphorylation (GO:0035970),1/89,0.0771722254871189,0.2028749685633873,0,0,13.29812834224599,34.06602362525984,PTPRB
304,GO_Biological_Process_2017b,activation of MAPK activity by adrenergic receptor signaling pathway (GO:0071883),1/90,0.0780064813617029,0.2028749685633873,0,0,13.148050231328488,33.54019441349092,NRG1
305,GO_Biological_Process_2017b,macroautophagy (GO:0016236),1/91,0.0788400249120094,0.2028749685633873,0,0,13.001307189542484,33.02766894797317,ATG16L1
306,GO_Biological_Process_2017b,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/91,0.0788400249120094,0.2028749685633873,0,0,13.001307189542484,33.02766894797317,NRG1
307,GO_Biological_Process_2017b,selective autophagy (GO:0061912),1/91,0.0788400249120094,0.2028749685633873,0,0,13.001307189542484,33.02766894797317,ATG16L1
299,GO_Biological_Process_2017b,cellular calcium ion homeostasis (GO:0006874),1/87,0.075501574519904,0.2028749685633873,0,0,13.60875512995896,35.15960381916263,LETMD1
308,GO_Biological_Process_2017b,histone dephosphorylation (GO:0016576),1/92,0.0796728567374856,0.2037204691262291,0,0,12.857789269553976,32.527973699604026,PTPRB
309,GO_Biological_Process_2017b,autophagosome organization (GO:1905037),1/93,0.0805049773808957,0.2045535274332193,0,0,12.717391304347826,32.040656856642045,ATG16L1
102,GO_Biological_Process_2018,"negative regulation of transcription, DNA-templated (GO:0045892)",2/813,0.1647955008025017,0.2063943650827449,0,0,2.9548397040690504,5.327723618605488,NRG1;ETV6
103,GO_Biological_Process_2018,"regulation of transcription, DNA-templated (GO:0006355)",3/1598,0.169683858780132,0.2104732479099714,0,0,2.305579937304075,4.0896797176792905,TFCP2;NRG1;ETV6
104,GO_Biological_Process_2018,positive regulation of phosphorylation (GO:0042327),1/208,0.1716008738327607,0.2108239307088203,0,0,5.619494174481387,9.904830518211895,VAC14
310,GO_Biological_Process_2017b,peptidyl-tyrosine dephosphorylation (GO:0035335),1/97,0.083826359716664,0.2116615582845766,0,0,12.185049019607844,30.20683114705019,PTPRB
311,GO_Biological_Process_2017b,phosphatidylinositol-mediated signaling (GO:0048015),1/99,0.0854827987095899,0.2145034203644368,0,0,11.935174069627852,29.35384580236193,NRG1
312,GO_Biological_Process_2017b,protein lipidation involved in autophagosome assembly (GO:0061739),1/100,0.0863099571505927,0.2152421153632066,0,0,11.81402257872846,28.942114306609312,ATG16L1
105,GO_Biological_Process_2018,protein oligomerization (GO:0051259),1/217,0.1783581615526625,0.2168317537741163,0,0,5.382897603485839,9.279908801665458,ATG16L1
106,GO_Biological_Process_2018,ion transmembrane transport (GO:0034220),1/219,0.1798526949909336,0.2168317537741163,0,0,5.332973556395035,9.149340756756814,KCND3
313,GO_Biological_Process_2017b,autophagosome maturation (GO:0097352),1/103,0.0887871950954723,0.2200615142243609,0,0,11.46482122260669,27.76221178459644,ATG16L1
314,GO_Biological_Process_2017b,GPI anchor biosynthetic process (GO:0006506),1/106,0.0912580888842393,0.2248065116416626,0,0,11.135574229691876,26.659273431080635,VAC14
107,GO_Biological_Process_2018,activation of protein kinase activity (GO:0032147),1/233,0.1902427648031118,0.2272344135148279,0,0,5.007606490872211,8.309894188622586,NRG1
315,GO_Biological_Process_2017b,positive regulation of protein targeting to mitochondrion (GO:1903955),1/113,0.0969989218002412,0.2375003903472572,0,0,10.4359243697479,24.3475898718272,NRG1
316,GO_Biological_Process_2017b,phosphatidylinositol 3-kinase signaling (GO:0014065),1/114,0.0978162392503257,0.238058799139347,0,0,10.343050494534095,24.04412406695568,NRG1
150,WikiPathways_2019_Human,Nuclear Receptors Meta-Pathway WP2882,1/319,0.2513904363966567,0.2513904363966567,0,0,3.637439881613023,5.022387932343224,NRG1
318,GO_Biological_Process_2017b,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/126,0.107569710770567,0.2586795425673159,0,0,9.344470588235296,20.83458271705315,NRG1
317,GO_Biological_Process_2017b,protein homotrimerization (GO:0070207),1/126,0.107569710770567,0.2586795425673159,0,0,9.344470588235296,20.83458271705315,ATG16L1
108,GO_Biological_Process_2018,cellular response to oxygen-containing compound (GO:1901701),1/274,0.2199603724552312,0.2603200738231636,0,0,4.246714070243482,6.430832555441595,FAM210B
109,GO_Biological_Process_2018,MAPK cascade (GO:0000165),1/278,0.2228038383368437,0.2612881376859349,0,0,4.184540242089616,6.282934619193975,NRG1
110,GO_Biological_Process_2018,negative regulation of signal transduction (GO:0009968),1/283,0.2263444052627623,0.2630489034134805,0,0,4.1093032957864,6.105181726167229,NRG1
319,GO_Biological_Process_2017b,activation of MAPK activity (GO:0000187),1/137,0.1164228335754234,0.2753390046086874,0,0,8.583910034602075,18.459926845841217,NRG1
322,GO_Biological_Process_2017b,autophagosome-lysosome fusion (GO:0061909),1/138,0.1172235366155797,0.2753390046086874,0,0,8.520824388149421,18.26585775015061,ATG16L1
320,GO_Biological_Process_2017b,amphisome-lysosome fusion (GO:0061911),1/138,0.1172235366155797,0.2753390046086874,0,0,8.520824388149421,18.26585775015061,ATG16L1
321,GO_Biological_Process_2017b,autophagosome-endosome fusion (GO:0061910),1/138,0.1172235366155797,0.2753390046086874,0,0,8.520824388149421,18.26585775015061,ATG16L1
323,GO_Biological_Process_2017b,activation of JUN kinase activity (GO:0007257),1/143,0.1212167829384625,0.283072718538375,0,0,8.218724109362055,17.34294402575858,NRG1
324,GO_Biological_Process_2017b,protein homooligomerization (GO:0051260),1/150,0.126778675360575,0.2943596830211052,0,0,7.82984603237268,16.171078308333918,ATG16L1
325,GO_Biological_Process_2017b,membrane repolarization (GO:0086009),1/173,0.1448203066701671,0.3324284312201564,0,0,6.7749658002735975,13.091006050059688,KCND3
326,GO_Biological_Process_2017b,protein homotetramerization (GO:0051289),1/173,0.1448203066701671,0.3324284312201564,0,0,6.7749658002735975,13.091006050059688,ATG16L1
111,GO_Biological_Process_2018,organelle assembly (GO:0070925),1/376,0.2894865214005407,0.3334264398274085,0,0,3.075607843137255,3.812666625001497,ATG16L1
112,GO_Biological_Process_2018,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/396,0.3024140385644269,0.3452337254408059,0,0,2.916902457185406,3.4884934470701143,NRG1
327,GO_Biological_Process_2017b,protein dephosphorylation (GO:0006470),1/186,0.1548614260771356,0.3534690177127841,0,0,6.294753577106518,11.741129142703194,PTPRB
113,GO_Biological_Process_2018,positive regulation of cell proliferation (GO:0008284),1/424,0.3201397912985814,0.3622634480483948,0,0,2.7199276873870115,3.097990919808182,NRG1
114,GO_Biological_Process_2018,negative regulation of nucleic acid-templated transcription (GO:1903507),1/444,0.3325396640061234,0.3730227535373036,0,0,2.5944761651839063,2.856508232180507,NRG1
115,GO_Biological_Process_2018,nervous system development (GO:0007399),1/455,0.3392682331069789,0.3772896730241403,0,0,2.5301891681782847,2.735044002052133,NRG1
116,GO_Biological_Process_2018,neutrophil degranulation (GO:0043312),1/479,0.3537270465373631,0.3821810228229246,0,0,2.400196898843219,2.494355946913392,PTPRB
118,GO_Biological_Process_2018,neutrophil activation involved in immune response (GO:0002283),1/483,0.3561076019979903,0.3821810228229246,0,0,2.379790090309983,2.4571864351258017,PTPRB
117,GO_Biological_Process_2018,positive regulation of intracellular signal transduction (GO:1902533),1/479,0.3537270465373631,0.3821810228229246,0,0,2.400196898843219,2.494355946913392,NRG1
120,GO_Biological_Process_2018,neutrophil mediated immunity (GO:0002446),1/487,0.3584798741207277,0.3821810228229246,0,0,2.3597191963205035,2.420795241124082,PTPRB
119,GO_Biological_Process_2018,transcription from RNA polymerase II promoter (GO:0006366),1/485,0.3572947717879314,0.3821810228229246,0,0,2.3697131745260087,2.438894928379322,TFCP2
384,GO_Biological_Process_2017b,regulation of transcription involved in cell fate commitment (GO:0060850),1/306,0.242435711456759,0.3924402477272177,0,0,3.7949855351976858,5.377565511905756,TFCP2
387,GO_Biological_Process_2017b,regulation of BMP signaling pathway (GO:0030510),1/309,0.2445111206602812,0.3924402477272177,0,0,3.757448433919022,5.29234540747443,TFCP2
388,GO_Biological_Process_2017b,regulation of androgen receptor activity (GO:2000823),1/309,0.2445111206602812,0.3924402477272177,0,0,3.757448433919022,5.29234540747443,TFCP2
389,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061396),1/309,0.2445111206602812,0.3924402477272177,0,0,3.757448433919022,5.29234540747443,TFCP2
390,GO_Biological_Process_2017b,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),1/311,0.2458917422740587,0.3924402477272177,0,0,3.7328273244781776,5.236648743113168,TFCP2
386,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/308,0.2438199149869709,0.3924402477272177,0,0,3.7698792872197737,5.320526315766718,TFCP2
385,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903756),1/306,0.242435711456759,0.3924402477272177,0,0,3.7949855351976858,5.377565511905756,TFCP2
392,GO_Biological_Process_2017b,regulation of SREBP signaling pathway (GO:2000638),1/318,0.2507051763859116,0.3924402477272177,0,0,3.6491000185563194,5.048448231807407,TFCP2
393,GO_Biological_Process_2017b,regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),1/322,0.2534426668930203,0.3924402477272177,0,0,3.6028953637529777,4.945397758861708,TFCP2
383,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034395),1/306,0.242435711456759,0.3924402477272177,0,0,3.7949855351976858,5.377565511905756,TFCP2
420,GO_Biological_Process_2017b,positive regulation of osteoblast proliferation (GO:0033690),1/335,0.2622744229860118,0.3924402477272177,0,0,3.4603733709052484,4.63123882575208,NRG1
381,GO_Biological_Process_2017b,regulation of glucose import by regulation of transcription from RNA polymerase II promoter (GO:1900389),1/304,0.2410491151382885,0.3924402477272177,0,0,3.820423218792468,5.435524590054537,TFCP2
380,GO_Biological_Process_2017b,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/303,0.2403549184307445,0.3924402477272177,0,0,3.833268406700428,5.46485548614398,TFCP2
394,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry (GO:1900094),1/324,0.2548078674156933,0.3924402477272177,0,0,3.580222181751958,4.895042591576459,TFCP2
379,GO_Biological_Process_2017b,regulation of cellular response to oxidative stress by regulation of transcription from RNA polymerase II promoter (GO:1900427),1/303,0.2403549184307445,0.3924402477272177,0,0,3.833268406700428,5.46485548614398,TFCP2
378,GO_Biological_Process_2017b,regulation of replicative cell aging by regulation of transcription from RNA polymerase II promoter in response to caloric restriction (GO:0061434),1/303,0.2403549184307445,0.3924402477272177,0,0,3.833268406700428,5.46485548614398,TFCP2
377,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter (GO:0072364),1/303,0.2403549184307445,0.3924402477272177,0,0,3.833268406700428,5.46485548614398,TFCP2
376,GO_Biological_Process_2017b,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter (GO:0072367),1/303,0.2403549184307445,0.3924402477272177,0,0,3.833268406700428,5.46485548614398,TFCP2
375,GO_Biological_Process_2017b,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter (GO:1900402),1/302,0.2396601220894562,0.3924402477272177,0,0,3.846198944694157,5.494424106700029,TFCP2
374,GO_Biological_Process_2017b,positive regulation of mating type switching by regulation of transcription from RNA polymerase II promoter (GO:1900374),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
373,GO_Biological_Process_2017b,regulation of phenotypic switching by regulation of transcription from RNA polymerase II promoter (GO:1900545),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
372,GO_Biological_Process_2017b,regulation of oligopeptide transport by regulation of transcription from RNA polymerase II promoter (GO:0035950),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
382,GO_Biological_Process_2017b,regulation of cAMP-mediated signaling by regulation of transcription from RNA polymerase II promoter (GO:1900391),1/305,0.2417427126329459,0.3924402477272177,0,0,3.8076625386996894,5.406428794785546,TFCP2
395,GO_Biological_Process_2017b,positive regulation of skeletal muscle cell proliferation (GO:0014858),1/327,0.2568512480614547,0.3924402477272177,0,0,3.546734031035727,4.820927183584267,NRG1
401,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in compound eye morphogenesis (GO:2000497),1/327,0.2568512480614547,0.3924402477272177,0,0,3.546734031035727,4.820927183584267,NRG1
397,GO_Biological_Process_2017b,positive regulation of cell proliferation in bone marrow (GO:0071864),1/327,0.2568512480614547,0.3924402477272177,0,0,3.546734031035727,4.820927183584267,NRG1
418,GO_Biological_Process_2017b,positive regulation of trophectodermal cell proliferation (GO:1904075),1/335,0.2622744229860118,0.3924402477272177,0,0,3.4603733709052484,4.63123882575208,NRG1
417,GO_Biological_Process_2017b,positive regulation of stem cell proliferation (GO:2000648),1/334,0.2615985760079172,0.3924402477272177,0,0,3.470941529765059,4.6543385755323365,NRG1
416,GO_Biological_Process_2017b,positive regulation of cardiac muscle cell proliferation (GO:0060045),1/334,0.2615985760079172,0.3924402477272177,0,0,3.470941529765059,4.6543385755323365,NRG1
415,GO_Biological_Process_2017b,central nervous system development (GO:0007417),1/333,0.2609221442988567,0.3924402477272177,0,0,3.4815733522324592,4.677609435230168,NRG1
414,GO_Biological_Process_2017b,positive regulation of myoblast proliferation (GO:2000288),1/330,0.2588893360476438,0.3924402477272177,0,0,3.513856606472376,4.748466227535915,NRG1
413,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in kidney development (GO:1901724),1/330,0.2588893360476438,0.3924402477272177,0,0,3.513856606472376,4.748466227535915,NRG1
371,GO_Biological_Process_2017b,carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
412,GO_Biological_Process_2017b,positive regulation of chondrocyte proliferation (GO:1902732),1/330,0.2588893360476438,0.3924402477272177,0,0,3.513856606472376,4.748466227535915,NRG1
411,GO_Biological_Process_2017b,positive regulation of glial cell proliferation (GO:0060252),1/330,0.2588893360476438,0.3924402477272177,0,0,3.513856606472376,4.748466227535915,NRG1
410,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138),1/329,0.2582105606693922,0.3924402477272177,0,0,3.524748923959828,4.772439196593552,NRG1
396,GO_Biological_Process_2017b,positive regulation of sebum secreting cell proliferation (GO:1904004),1/327,0.2568512480614547,0.3924402477272177,0,0,3.546734031035727,4.820927183584267,NRG1
409,GO_Biological_Process_2017b,positive regulation of mesenchymal cell proliferation (GO:0002053),1/329,0.2582105606693922,0.3924402477272177,0,0,3.524748923959828,4.772439196593552,NRG1
407,GO_Biological_Process_2017b,positive regulation of hair follicle cell proliferation (GO:0071338),1/328,0.2575311981638886,0.3924402477272177,0,0,3.535707861126102,4.796592227940982,NRG1
406,GO_Biological_Process_2017b,positive regulation of chorionic trophoblast cell proliferation (GO:1901384),1/328,0.2575311981638886,0.3924402477272177,0,0,3.535707861126102,4.796592227940982,NRG1
405,GO_Biological_Process_2017b,positive regulation of hemocyte proliferation (GO:0035208),1/328,0.2575311981638886,0.3924402477272177,0,0,3.535707861126102,4.796592227940982,NRG1
404,GO_Biological_Process_2017b,positive regulation of secondary heart field cardioblast proliferation (GO:0072513),1/328,0.2575311981638886,0.3924402477272177,0,0,3.535707861126102,4.796592227940982,NRG1
403,GO_Biological_Process_2017b,positive regulation of germ cell proliferation (GO:1905938),1/327,0.2568512480614547,0.3924402477272177,0,0,3.546734031035727,4.820927183584267,NRG1
402,GO_Biological_Process_2017b,positive regulation of leukocyte proliferation (GO:0070665),1/327,0.2568512480614547,0.3924402477272177,0,0,3.546734031035727,4.820927183584267,NRG1
419,GO_Biological_Process_2017b,positive regulation of neural precursor cell proliferation (GO:2000179),1/335,0.2622744229860118,0.3924402477272177,0,0,3.4603733709052484,4.63123882575208,NRG1
400,GO_Biological_Process_2017b,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091),1/327,0.2568512480614547,0.3924402477272177,0,0,3.546734031035727,4.820927183584267,NRG1
399,GO_Biological_Process_2017b,positive regulation of mammary stem cell proliferation (GO:2000103),1/327,0.2568512480614547,0.3924402477272177,0,0,3.546734031035727,4.820927183584267,NRG1
398,GO_Biological_Process_2017b,positive regulation of synoviocyte proliferation (GO:1901647),1/327,0.2568512480614547,0.3924402477272177,0,0,3.546734031035727,4.820927183584267,NRG1
408,GO_Biological_Process_2017b,positive regulation of fat cell proliferation (GO:0070346),1/328,0.2575311981638886,0.3924402477272177,0,0,3.535707861126102,4.796592227940982,NRG1
370,GO_Biological_Process_2017b,regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901580),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
391,GO_Biological_Process_2017b,regulation of transcription involved in anterior/posterior axis specification (GO:0044324),1/311,0.2458917422740587,0.3924402477272177,0,0,3.7328273244781776,5.236648743113168,TFCP2
368,GO_Biological_Process_2017b,nitrogen catabolite regulation of transcription from RNA polymerase II promoter (GO:0001079),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
344,GO_Biological_Process_2017b,synapse assembly (GO:0007416),1/285,0.2277563622133903,0.3924402477272177,0,0,4.079950289975145,6.036199992352182,NRG1
343,GO_Biological_Process_2017b,MAPK import into nucleus (GO:0000189),1/273,0.2192479723428101,0.3924402477272177,0,0,4.262543252595155,6.468630594433781,NRG1
342,GO_Biological_Process_2017b,neurogenesis (GO:0022008),1/272,0.218534957795225,0.3924402477272177,0,0,4.27848925548079,6.506766195493984,NRG1
341,GO_Biological_Process_2017b,determination of left/right asymmetry in nervous system (GO:0035545),1/270,0.2171070833728527,0.3924402477272177,0,0,4.310736934178876,6.584066887109633,NRG1
340,GO_Biological_Process_2017b,neural tube development (GO:0021915),1/259,0.2092096263302128,0.3924402477272177,0,0,4.49703602371181,7.0352464985563365,NRG1
339,GO_Biological_Process_2017b,peripheral nervous system development (GO:0007422),1/255,0.2063192149941518,0.3924402477272177,0,0,4.56878184344604,7.211048746604039,NRG1
338,GO_Biological_Process_2017b,stress-activated MAPK cascade (GO:0051403),1/250,0.2026921685902864,0.3924402477272177,0,0,4.661705646113867,7.440393900949895,NRG1
337,GO_Biological_Process_2017b,ERK1 and ERK2 cascade (GO:0070371),1/245,0.1990494717477533,0.3924402477272177,0,0,4.758437801350048,7.681079261011621,NRG1
345,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in lung bud formation (GO:0060500),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
336,GO_Biological_Process_2017b,autonomic nervous system development (GO:0048483),1/245,0.1990494717477533,0.3924402477272177,0,0,4.758437801350048,7.681079261011621,NRG1
334,GO_Biological_Process_2017b,ganglion development (GO:0061548),1/244,0.1983190487272474,0.3924402477272177,0,0,4.778261922052772,7.730645739869231,NRG1
333,GO_Biological_Process_2017b,stomatogastric nervous system development (GO:0007421),1/244,0.1983190487272474,0.3924402477272177,0,0,4.778261922052772,7.730645739869231,NRG1
332,GO_Biological_Process_2017b,MAPK cascade involved in axon regeneration (GO:1903616),1/237,0.193188445176418,0.3924402477272177,0,0,4.921734795613161,8.091770858187086,NRG1
331,GO_Biological_Process_2017b,MAPK cascade involved in innate immune response (GO:0035420),1/232,0.1895047592338975,0.3924402477272177,0,0,5.029539088362617,8.36583928133549,NRG1
330,GO_Biological_Process_2017b,MAPK cascade involved in osmosensory signaling pathway (GO:0000161),1/232,0.1895047592338975,0.3924402477272177,0,0,5.029539088362617,8.36583928133549,NRG1
329,GO_Biological_Process_2017b,ERK5 cascade (GO:0070375),1/232,0.1895047592338975,0.3924402477272177,0,0,5.029539088362617,8.36583928133549,NRG1
328,GO_Biological_Process_2017b,MAPK cascade (GO:0000165),1/232,0.1895047592338975,0.3924402477272177,0,0,5.029539088362617,8.36583928133549,NRG1
369,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0046021),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
335,GO_Biological_Process_2017b,nervous system development (GO:0007399),1/244,0.1983190487272474,0.3924402477272177,0,0,4.778261922052772,7.730645739869231,NRG1
347,GO_Biological_Process_2017b,regulation of transcription involved in posterior neural plate formation (GO:0090020),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
346,GO_Biological_Process_2017b,regulation of thiamine biosynthetic process by regulation of transcription from RNA polymerase II promoter (GO:1900382),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
359,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in spinal cord anterior-posterior patterning (GO:0021909),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
365,GO_Biological_Process_2017b,regulation of iron ion transport by regulation of transcription from RNA polymerase II promoter (GO:1900393),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
364,GO_Biological_Process_2017b,regulation of transcription involved in anterior neural plate formation (GO:0090019),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
363,GO_Biological_Process_2017b,positive regulation of phenotypic switching by regulation of transcription from RNA polymerase II promoter (GO:1900546),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
362,GO_Biological_Process_2017b,regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900145),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
361,GO_Biological_Process_2017b,regulation of snRNA transcription from RNA polymerase II promoter (GO:1905380),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
360,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in mammary gland formation (GO:0060597),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
348,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in somitogenesis (GO:0090236),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
358,GO_Biological_Process_2017b,regulation of ergosterol biosynthetic process by regulation of transcription from RNA polymerase II promoter (GO:0035960),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
357,GO_Biological_Process_2017b,regulation of pyrimidine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900448),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
356,GO_Biological_Process_2017b,regulation of fungal-type cell wall biogenesis by regulation of transcription from RNA polymerase II promoter (GO:1900415),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
355,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter in response to methionine (GO:0061432),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
354,GO_Biological_Process_2017b,regulation of mating-type specific transcription from RNA polymerase II promoter (GO:0001196),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
353,GO_Biological_Process_2017b,regulation of termination of RNA polymerase II transcription (GO:1904594),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
352,GO_Biological_Process_2017b,regulation of thyroid hormone receptor activity (GO:1904167),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
351,GO_Biological_Process_2017b,negative regulation of leucine import by regulation of transcription from RNA polymerase II promoter (GO:1902574),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
350,GO_Biological_Process_2017b,regulation of conjugation with cellular fusion by regulation of transcription from RNA polymerase II promoter (GO:1900406),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
349,GO_Biological_Process_2017b,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
366,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046019),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
367,GO_Biological_Process_2017b,regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0060962),1/301,0.2389647255884729,0.3924402477272177,0,0,3.85921568627451,5.524233114832815,TFCP2
422,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling (GO:1900621),1/338,0.2642984602347566,0.3925609482898592,0,0,3.429045208587886,4.56294913313209,TFCP2
421,GO_Biological_Process_2017b,positive regulation of growth plate cartilage chondrocyte proliferation (GO:0061913),1/337,0.2636243646110588,0.3925609482898592,0,0,3.4394257703081235,4.585545793046719,NRG1
423,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in kidney development (GO:0060994),1/340,0.2656449034643591,0.3931155347970736,0,0,3.4084678119035225,4.51824724635571,TFCP2
121,GO_Biological_Process_2018,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/512,0.3731205884798869,0.3945291468352902,0,0,2.241395188212272,2.209687555834172,NRG1
122,GO_Biological_Process_2018,positive regulation of cellular process (GO:0048522),1/519,0.3771630883220924,0.3955612877524384,0,0,2.210311151487622,2.155224870869906,NRG1
424,GO_Biological_Process_2017b,positive regulation of fibroblast proliferation (GO:0048146),1/345,0.2690008369044981,0.3966289712022526,0,0,3.3580711354309165,4.409284370551608,NRG1
425,GO_Biological_Process_2017b,positive regulation of smooth muscle cell proliferation (GO:0048661),1/347,0.2703391503064064,0.3966920482934797,0,0,3.338320299217953,4.366783326963017,NRG1
426,GO_Biological_Process_2017b,positive regulation of epithelial cell proliferation (GO:0050679),1/348,0.2710074389331693,0.3966920482934797,0,0,3.3285302593659942,4.345759091830501,NRG1
427,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),2/1175,0.2859249782638498,0.4159448402867573,0,0,2.004369138959932,2.509521907443631,CSRNP2;TFCP2
428,GO_Biological_Process_2017b,torso signaling pathway (GO:0008293),1/371,0.286219469306234,0.4159448402867573,0,0,3.117965023847377,3.900562980397035,TFCP2
123,GO_Biological_Process_2018,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),1/565,0.4031218621353314,0.4193767759311109,0,0,2.025239883187317,1.8399635978121285,ETV6
429,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213),1/378,0.290789383590036,0.4210713654852134,0,0,3.058979559993759,3.778317084622917,TFCP2
430,GO_Biological_Process_2017b,BMP signaling pathway (GO:0030509),1/381,0.2927394469617987,0.422381202044881,0,0,3.0343653250773994,3.727633826121644,TFCP2
471,GO_Biological_Process_2017b,regulation of transport by negative regulation of transcription from RNA polymerase II promoter (GO:1900392),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
470,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046020),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
469,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
468,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072365),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
467,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034396),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
466,GO_Biological_Process_2017b,negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter (GO:0035952),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
487,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/485,0.3572947717879314,0.426661608886474,0,0,2.3697131745260087,2.438894928379322,ETV6
464,GO_Biological_Process_2017b,carbon catabolite repression of transcription from RNA polymerase II promoter (GO:0000437),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
472,GO_Biological_Process_2017b,transfer RNA gene-mediated silencing (GO:0061587),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
463,GO_Biological_Process_2017b,negative regulation of cellular response to alkaline pH by negative regulation of transcription from RNA polymerase II promoter (GO:1900463),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
490,GO_Biological_Process_2017b,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/488,0.3590716510430721,0.426661608886474,0,0,2.3547529894914843,2.411816484757892,ETV6
461,GO_Biological_Process_2017b,negative regulation of phosphatidylserine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900526),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
460,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061398),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
465,GO_Biological_Process_2017b,negative regulation of phosphatidylcholine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900473),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
473,GO_Biological_Process_2017b,negative regulation of induction of conjugation with cellular fusion by negative regulation of transcription from RNA polymerase II promoter (GO:1902625),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
478,GO_Biological_Process_2017b,negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581),1/482,0.3555132407904096,0.426661608886474,0,0,2.384859973095267,2.4664049771475995,ETV6
475,GO_Biological_Process_2017b,negative regulation of mating type switching by negative regulation of transcription from RNA polymerase II promoter (GO:1900474),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
476,GO_Biological_Process_2017b,negative regulation of snRNA transcription from RNA polymerase II promoter (GO:1905381),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
477,GO_Biological_Process_2017b,negative regulation of inositol biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900471),1/482,0.3555132407904096,0.426661608886474,0,0,2.384859973095267,2.4664049771475995,ETV6
488,GO_Biological_Process_2017b,neutrophil degranulation (GO:0043312),1/487,0.3584798741207277,0.426661608886474,0,0,2.3597191963205035,2.420795241124082,PTPRB
479,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0007070),1/482,0.3555132407904096,0.426661608886474,0,0,2.384859973095267,2.4664049771475995,ETV6
480,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903758),1/482,0.3555132407904096,0.426661608886474,0,0,2.384859973095267,2.4664049771475995,ETV6
481,GO_Biological_Process_2017b,negative regulation of mitochondrial unfolded protein response by negative regulation of transcription from RNA polymerase II promoter (GO:1904490),1/483,0.3561076019979903,0.426661608886474,0,0,2.379790090309983,2.4571864351258017,ETV6
482,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768),1/484,0.3567014455371644,0.426661608886474,0,0,2.374741200828157,2.4480165337649344,ETV6
483,GO_Biological_Process_2017b,negative regulation of ceramide biosynthetic process by negative regulation of transcription from RNA Polymerase II promoter (GO:0061427),1/484,0.3567014455371644,0.426661608886474,0,0,2.374741200828157,2.4480165337649344,ETV6
484,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by negative regulation of transcription from RNA polymerase II promoter (GO:0035949),1/484,0.3567014455371644,0.426661608886474,0,0,2.374741200828157,2.4480165337649344,ETV6
459,GO_Biological_Process_2017b,negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0010688),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
489,GO_Biological_Process_2017b,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),1/487,0.3584798741207277,0.426661608886474,0,0,2.3597191963205035,2.420795241124082,ETV6
485,GO_Biological_Process_2017b,negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633),1/484,0.3567014455371644,0.426661608886474,0,0,2.374741200828157,2.4480165337649344,ETV6
486,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820),1/484,0.3567014455371644,0.426661608886474,0,0,2.374741200828157,2.4480165337649344,ETV6
474,GO_Biological_Process_2017b,negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter (GO:1900460),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
458,GO_Biological_Process_2017b,negative regulation of filamentous growth of a population of unicellular organisms in response to starvation by negative regulation of transcription from RNA polymerase II promoter (GO:1902352),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
462,GO_Biological_Process_2017b,"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)",1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
456,GO_Biological_Process_2017b,negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter (GO:1900462),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
457,GO_Biological_Process_2017b,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter (GO:0072368),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
431,GO_Biological_Process_2017b,nitrogen catabolite repression of transcription (GO:0090295),1/412,0.3125957726416894,0.426661608886474,0,0,2.801059109775297,3.2571958559095866,NRG1
432,GO_Biological_Process_2017b,negative regulation of antisense RNA transcription (GO:0060195),1/412,0.3125957726416894,0.426661608886474,0,0,2.801059109775297,3.2571958559095866,NRG1
433,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase V promoter (GO:1904280),1/412,0.3125957726416894,0.426661608886474,0,0,2.801059109775297,3.2571958559095866,NRG1
434,GO_Biological_Process_2017b,"negative regulation of cellular carbohydrate metabolic process by negative regulation of transcription, DNA-templated (GO:0010678)",1/412,0.3125957726416894,0.426661608886474,0,0,2.801059109775297,3.2571958559095866,NRG1
435,GO_Biological_Process_2017b,negative regulation of transcription by pheromones (GO:0045996),1/412,0.3125957726416894,0.426661608886474,0,0,2.801059109775297,3.2571958559095866,NRG1
436,GO_Biological_Process_2017b,negative regulation of ncRNA transcription associated with protein coding gene TSS/TES (GO:1904388),1/412,0.3125957726416894,0.426661608886474,0,0,2.801059109775297,3.2571958559095866,NRG1
437,GO_Biological_Process_2017b,"negative regulation of mating-type specific transcription, DNA-templated (GO:0045894)",1/412,0.3125957726416894,0.426661608886474,0,0,2.801059109775297,3.2571958559095866,NRG1
438,GO_Biological_Process_2017b,negative regulation of transcription during mitotic cell cycle (GO:0007068),1/412,0.3125957726416894,0.426661608886474,0,0,2.801059109775297,3.2571958559095866,NRG1
439,GO_Biological_Process_2017b,chromatin organization involved in negative regulation of transcription (GO:0097549),1/412,0.3125957726416894,0.426661608886474,0,0,2.801059109775297,3.2571958559095866,NRG1
440,GO_Biological_Process_2017b,negative regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090419),1/413,0.3132274480371527,0.426661608886474,0,0,2.794117647058824,3.243483521263582,NRG1
441,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor catabolism (GO:0010620),1/413,0.3132274480371527,0.426661608886474,0,0,2.794117647058824,3.243483521263582,NRG1
442,GO_Biological_Process_2017b,carbon catabolite repression of transcription (GO:0045013),1/413,0.3132274480371527,0.426661608886474,0,0,2.794117647058824,3.243483521263582,NRG1
444,GO_Biological_Process_2017b,negative regulation of transcription by competitive promoter binding (GO:0010944),1/416,0.3151191864364795,0.426661608886474,0,0,2.7734939759036146,3.2028428861079568,NRG1
445,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase I promoter (GO:0016479),1/419,0.3170060027221026,0.426661608886474,0,0,2.753166338305657,3.162932664347233,NRG1
446,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081),1/419,0.3170060027221026,0.426661608886474,0,0,2.753166338305657,3.162932664347233,NRG1
447,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",1/422,0.3188879089964254,0.426661608886474,0,0,2.733128405756602,3.12373514750615,NRG1
448,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase III promoter (GO:0016480),1/423,0.3195141220333955,0.426661608886474,0,0,2.7265124059102317,3.1108247058765524,NRG1
449,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, initiation (GO:2000143)",1/424,0.3201397912985814,0.426661608886474,0,0,2.7199276873870115,3.097990919808182,NRG1
450,GO_Biological_Process_2017b,negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930),1/430,0.3238824122261437,0.426661608886474,0,0,2.6810640340052103,3.022563906575217,NRG1
451,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor localization (GO:0010621),1/432,0.3251256223791802,0.426661608886474,0,0,2.668349938583322,2.9980076052940663,NRG1
452,GO_Biological_Process_2017b,positive regulation of cell proliferation (GO:0008284),1/442,0.3313093560685172,0.426661608886474,0,0,2.6065092703748167,2.879417905717563,NRG1
453,GO_Biological_Process_2017b,negative regulation of cellular hyperosmotic salinity response by negative regulation of transcription from RNA polymerase II promoter (GO:1900464),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
454,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010674),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
455,GO_Biological_Process_2017b,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072362),1/481,0.3549183614192739,0.426661608886474,0,0,2.389950980392157,2.475672508431685,ETV6
443,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, termination (GO:0060567)",1/414,0.3138585751214838,0.426661608886474,0,0,2.787209799173907,3.2298543699273514,NRG1
492,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904489),1/492,0.3614336070593208,0.4269566586314784,0,0,2.335090451659279,2.376367644376603,ETV6
491,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter (GO:1900387),1/491,0.3608438899822768,0.4269566586314784,0,0,2.3399759903961583,2.3851605802194147,ETV6
493,GO_Biological_Process_2017b,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477),1/496,0.3637873406483042,0.4284842146411514,0,0,2.3157456922162805,2.34164918599665,ETV6
124,GO_Biological_Process_2018,negative regulation of gene expression (GO:0010629),1/618,0.4317634648645763,0.4455798957402427,0,0,1.8462198493660025,1.5505982820983557,NRG1
494,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904089),1/534,0.3857428343305875,0.4530235612487133,0,0,2.146451826509215,2.044676447696062,ETV6
495,GO_Biological_Process_2017b,phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),1/596,0.4200357721622747,0.4918679766769826,0,0,1.9166584280771133,1.6625390361275525,TFCP2
544,GO_Biological_Process_2017b,regulation of potassium ion concentration by positive regulation of transcription from RNA polymerase II promoter (GO:0097301),1/728,0.4871182762124091,0.4968887357115528,0,0,1.557973946112145,1.1205701408849242,CSRNP2
523,GO_Biological_Process_2017b,positive regulation of starch catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035957),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
524,GO_Biological_Process_2017b,positive regulation of transcription via serum response element binding (GO:0010735),1/721,0.4837532099670621,0.4968887357115528,0,0,1.5736928104575163,1.142784873110582,CSRNP2
525,GO_Biological_Process_2017b,transcriptional activation by promoter-enhancer looping (GO:0071733),1/721,0.4837532099670621,0.4968887357115528,0,0,1.5736928104575163,1.142784873110582,CSRNP2
526,GO_Biological_Process_2017b,positive regulation of terminal gap gene transcription (GO:0007363),1/721,0.4837532099670621,0.4968887357115528,0,0,1.5736928104575163,1.142784873110582,CSRNP2
527,GO_Biological_Process_2017b,positive regulation of posterior gap gene transcription (GO:0007360),1/721,0.4837532099670621,0.4968887357115528,0,0,1.5736928104575163,1.142784873110582,CSRNP2
528,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721),1/721,0.4837532099670621,0.4968887357115528,0,0,1.5736928104575163,1.142784873110582,CSRNP2
529,GO_Biological_Process_2017b,positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282),1/721,0.4837532099670621,0.4968887357115528,0,0,1.5736928104575163,1.142784873110582,CSRNP2
530,GO_Biological_Process_2017b,positive regulation of phospholipid biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900413),1/721,0.4837532099670621,0.4968887357115528,0,0,1.5736928104575163,1.142784873110582,CSRNP2
531,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0046022),1/721,0.4837532099670621,0.4968887357115528,0,0,1.5736928104575163,1.142784873110582,CSRNP2
532,GO_Biological_Process_2017b,positive regulation of inositol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900375),1/721,0.4837532099670621,0.4968887357115528,0,0,1.5736928104575163,1.142784873110582,CSRNP2
533,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/722,0.4842352070875041,0.4968887357115528,0,0,1.5714285714285714,1.139575682538001,CSRNP2
548,GO_Biological_Process_2017b,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),1/733,0.4895092000326683,0.4968887357115528,0,0,1.5469302475088396,1.1050527508707135,CSRNP2
535,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/724,0.4851979265596331,0.4968887357115528,0,0,1.566918883736067,1.133193190935309,CSRNP2
522,GO_Biological_Process_2017b,positive regulation of filamentous growth of a population of unicellular organisms in response to starvation by positive regulation of transcription from RNA polymerase II promoter (GO:1904741),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
536,GO_Biological_Process_2017b,SREBP signaling pathway (GO:0032933),1/725,0.4856786495626825,0.4968887357115528,0,0,1.564673383165421,1.130019773452194,CSRNP2
537,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763),1/725,0.4856786495626825,0.4968887357115528,0,0,1.564673383165421,1.130019773452194,CSRNP2
538,GO_Biological_Process_2017b,positive regulation of central gap gene transcription (GO:0007357),1/725,0.4856786495626825,0.4968887357115528,0,0,1.564673383165421,1.130019773452194,CSRNP2
539,GO_Biological_Process_2017b,positive regulation of SREBP signaling pathway (GO:2000640),1/725,0.4856786495626825,0.4968887357115528,0,0,1.564673383165421,1.130019773452194,CSRNP2
540,GO_Biological_Process_2017b,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),1/725,0.4856786495626825,0.4968887357115528,0,0,1.564673383165421,1.130019773452194,CSRNP2
541,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation (GO:0036278),1/725,0.4856786495626825,0.4968887357115528,0,0,1.564673383165421,1.130019773452194,CSRNP2
542,GO_Biological_Process_2017b,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/726,0.486158948639852,0.4968887357115528,0,0,1.5624340770791074,1.12685816405929,CSRNP2
543,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402),1/727,0.4866388240637988,0.4968887357115528,0,0,1.5602009398800842,1.1237083055889487,CSRNP2
547,GO_Biological_Process_2017b,positive regulation of sodium ion transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061423),1/731,0.4885540964858179,0.4968887357115528,0,0,1.5513295729250605,1.1112252439725694,CSRNP2
546,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to fungus (GO:1901244),1/730,0.4880759120548141,0.4968887357115528,0,0,1.5535382877430808,1.1143286663381513,CSRNP2
545,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1904488),1/729,0.4875973054306829,0.4968887357115528,0,0,1.5557530704589528,1.11744361324453,CSRNP2
534,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter (GO:0035948),1/723,0.4847167791599755,0.4968887357115528,0,0,1.5691706045299003,1.1363784746680536,CSRNP2
521,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010673),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
506,GO_Biological_Process_2017b,positive regulation of sulfate assimilation by positive regulation of transcription from RNA polymerase II promoter (GO:1900478),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
519,GO_Biological_Process_2017b,positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0061425),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
496,GO_Biological_Process_2017b,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter (GO:0072369),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
497,GO_Biological_Process_2017b,positive regulation of pyrimidine-containing compound salvage by positive regulation of transcription from RNA polymerase II promoter (GO:1904001),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
498,GO_Biological_Process_2017b,positive regulation of ergosterol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035961),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
499,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903757),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
500,GO_Biological_Process_2017b,positive regulation of oligopeptide transport by positive regulation of transcription from RNA polymerase II promoter (GO:0035951),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
501,GO_Biological_Process_2017b,positive regulation of mating type switching by positive regulation of transcription from RNA polymerase II promoter (GO:1900423),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
520,GO_Biological_Process_2017b,positive regulation of cellular alcohol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900422),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
503,GO_Biological_Process_2017b,positive regulation of invasive growth in response to glucose limitation by positive regulation of transcription from RNA polymerase II promoter (GO:0036095),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
504,GO_Biological_Process_2017b,positive regulation of sulfite transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061426),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
505,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072366),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
507,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling (GO:1900622),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
502,GO_Biological_Process_2017b,positive regulation of flocculation via cell wall protein-carbohydrate interaction by positive regulation of transcription from RNA polymerase II promoter (GO:1900524),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
509,GO_Biological_Process_2017b,positive regulation of snRNA transcription from RNA polymerase II promoter (GO:1905382),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
510,GO_Biological_Process_2017b,positive regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0060963),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
511,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
512,GO_Biological_Process_2017b,positive regulation of purine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900418),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
513,GO_Biological_Process_2017b,positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
514,GO_Biological_Process_2017b,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072363),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
515,GO_Biological_Process_2017b,positive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter (GO:1900461),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
516,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in stress response to cadmium ion (GO:1902901),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
517,GO_Biological_Process_2017b,positive regulation of peroxisome organization by positive regulation of transcription from RNA polymerase II promoter (GO:0061424),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
518,GO_Biological_Process_2017b,transcriptional activation by promoter-terminator looping (GO:0090203),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
508,GO_Biological_Process_2017b,positive regulation of termination of RNA polymerase II transcription (GO:1904595),1/720,0.4832707874982981,0.4968887357115528,0,0,1.575963347786959,1.1460061050690529,CSRNP2
549,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter (GO:0006357),1/736,0.4909386973615136,0.4970908113635375,0,0,1.540376150460184,1.095879064857264,TFCP2
550,GO_Biological_Process_2017b,positive regulation of DNA repair by positive regulation of transcription from RNA polymerase II promoter (GO:1900404),1/739,0.4923644136300784,0.4972880577663792,0,0,1.5338753387533874,1.0868061402096492,CSRNP2
551,GO_Biological_Process_2017b,positive regulation of transcription of Notch receptor target (GO:0007221),1/744,0.4947322303753704,0.4984334690066076,0,0,1.5231573113767714,1.0719046114281638,CSRNP2
552,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to Gram-negative bacterium (GO:1902097),1/756,0.5003725037638211,0.5028619192054322,0,0,1.4980132450331125,1.0372280416115367,CSRNP2
125,GO_Biological_Process_2018,regulation of cell proliferation (GO:0042127),1/740,0.4928388137103572,0.5045730711796513,0,0,1.531720130542068,1.0838039737777705,NRG1
553,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation (GO:1904081),1/770,0.5068776612899408,0.5081354222360697,0,0,1.4696703128585635,0.9986198198302556,CSRNP2
126,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),1/848,0.5416809069633209,0.5502113149469953,0,0,1.3289117299812487,0.8147267893870057,CSRNP2
554,GO_Biological_Process_2017b,"negative regulation of transcription, DNA-templated (GO:0045892)",1/895,0.5615179494599428,0.5615179494599428,0,0,1.255954730885643,0.7248259668184922,NRG1
127,GO_Biological_Process_2018,cellular protein modification process (GO:0006464),1/1001,0.6033210645171119,0.6080345103336519,0,0,1.1165882352941177,0.5642184876685615,PTPRB
128,GO_Biological_Process_2018,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1120,0.6457582943028364,0.6457582943028364,0,0,0.9915891289491668,0.4336516763809753,CSRNP2
